- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03186508
Enhancing Sleep Duration: Effects on Children's Eating and Activity Behaviors-Renewal
January 3, 2024 updated by: Temple University
Enhancing children's sleep may be a novel approach for prevention of obesity and cardiovascular (CV) disturbance.
Observational studies with children demonstrate that short sleep increases risk of obesity and other CV risk factors.
Randomized controlled trials with children 8-11 years old demonstrate that enhancing sleep duration leads to positive changes in eating and activity behaviors and weight status, particularly for children who enhance their sleep the most.
Enhancing sleep may be particularly important for racial minority children and those from lower socioeconomic backgrounds given their increased risk for short sleep, obesity and CV risk factors.
In this study two active obesity preventive interventions will be evaluated: a) enhancing sleep alone (Optimize Sleep [OS]), and b) enhancing sleep along with eating and activity behaviors that have demonstrated efficacy for obesity prevention and are implicated in self-regulatory pathways related to sleep (i.e., energy dense snack foods and beverages, TV viewing, and physical activity) (OS-Plus).
Two hundred four children 6-11 years old who are primarily African American/black, primarily from low socioeconomic backgrounds, and who sleep < 9.5 hours/night into a 12-month study will be enrolled.
Children will be randomly assigned to either OS or OS-Plus.
Over the 6-month treatment phase, all children will attend an 8-session treatment; monthly phone contacts will occur during maintenance (6-12 months).
Primary aim is to determine the efficacy of OS-Plus relative to OS on change in body mass index z-score (BMIz) at end of treatment.
Secondary aims will assess efficacy of OS-Plus relative to OS on additional cardiometabolic risk factors, eating and activity behaviors.
Exploratory aims will assess maintenance of effects at 12 months.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
149
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ashley Greer, MPH
- Phone Number: 215-707-8998
- Email: ashley.greer@temple.edu
Study Contact Backup
- Name: Chantelle N Hart, PhD
- Phone Number: 215-707-8639
- Email: chantelle.hart@temple.edu
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19122-6091
- Temple University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 11 years (Child)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Caregiver-reported child age of 6-11 years
- < 9.5 Hours time-in-bed for sleep most days/week
- BMI for age and gender > 25th percentile (but no greater than 100% overweight)
- Understanding of and ability to complete protocol
- Self-reported caregiver age of 18 years and primary caregiver at bedtimes/wake times
- Likes food used in the eating regulation paradigms
- Willingness to be randomized to either treatment condition.
Exclusion Criteria:
- Diagnosable sleep disorder
- Medication use or diagnosis of medical or psychiatric condition that may impact sleep/weight status
- Current or planned treatment for weight control
- Allergies or dietary restrictions that would prevent consumption of foods used in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Optimize Sleep (OS)
Optimize Sleep will focus exclusively on enhancing sleep by using effective behavioral strategies.
Specific strategies to be used include: goal setting and self-monitoring, positive bedtime routines, stimulus control/sleep hygiene strategies, problem-solving regarding challenges, and review of effective strategies for relapse prevention.
|
All children will receive 8 sessions during active treatment: two in-person weekly, three in-person biweekly, and 3 monthly sessions conducted by phone.
All families will be asked to complete 3 "sleep challenges" (at weeks 8, 16, and 20).
During maintenance, families will continue with monthly phone contact.
|
Active Comparator: Optimize Sleep-Plus (OS-Plus)
OS-Plus will focus on enhancing sleep and targeted eating (decreasing sugar-sweetened beverages and sweet and salty snack foods) and activity (increasing physical activity and decreasing TV viewing) behaviors.
Specific strategies to be used include: goal setting and self-monitoring, positive bedtime routines, stimulus control/sleep hygiene strategies, problem-solving regarding challenges, and review of effective strategies for relapse prevention.
|
All children will receive 8 sessions during active treatment: two in-person weekly, three in-person biweekly, and 3 monthly sessions conducted by phone.
All families will be asked to complete 3 "sleep challenges" (at weeks 8, 16, and 20).
During maintenance, families will continue with monthly phone contact.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in BMIz
Time Frame: Change from baseline BMIz at 6 months
|
change in body mass index z-score (accounting for child age and sex)
|
Change from baseline BMIz at 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Body Composition
Time Frame: Change from baseline percent body fat at 6 months
|
change in body composition (% body fat) will be estimated by air displacement plethysmography (BOD POD®; Life Measurement Instruments, Concord, CA)
|
Change from baseline percent body fat at 6 months
|
Change in Waist Circumference
Time Frame: Change from baseline waist circumference at 6 months
|
Change in measured waist circumference
|
Change from baseline waist circumference at 6 months
|
Change in Insulin Resistance
Time Frame: Change from baseline HOMA-IR at 6 months
|
Change in the homeostatic model assessment of insulin resistance (HOMA-IR)
|
Change from baseline HOMA-IR at 6 months
|
Change in Blood Glucose Levels
Time Frame: Change from baseline blood glucose levels at 6 months
|
2-hour blood glucose levels measured within the context of an oral glucose tolerance test
|
Change from baseline blood glucose levels at 6 months
|
Change in Non-HDL cholesterol (non-HDL-C)
Time Frame: Change from baseline in Non-HDL-C at 6 months
|
Total cholesterol (TC) minus HDL-C, includes LDL-C, VLDL-C, and atherogenic apo-B containing lipoproteins
|
Change from baseline in Non-HDL-C at 6 months
|
Change in Insulin Sensitivity Index (ISI)
Time Frame: Change from baseline ISI at 6 months
|
Insulin Sensitivity Index measured within the context of an oral glucose tolerance test
|
Change from baseline ISI at 6 months
|
Change in Sleep Period
Time Frame: Change from baseline in the sleep period at 6 months
|
Wrist-worn actigraphy
|
Change from baseline in the sleep period at 6 months
|
Change in Caloric Intake
Time Frame: Change from baseline in caloric intake at 6 months
|
24-hr dietary recalls on two days used to estimate caloric intake
|
Change from baseline in caloric intake at 6 months
|
Change in Food Reinforcement
Time Frame: Change from baseline in food reinforcement at 6 months
|
Measured using a validated computer activity (Behavioral Choice Task), which assesses motivation for a food reward
|
Change from baseline in food reinforcement at 6 months
|
Change in Eating in the Absence of Hunger (EAH)
Time Frame: Change from baseline in EAH at 6 months
|
Food consumed within the context of the eating in the absence of hunger paradigm
|
Change from baseline in EAH at 6 months
|
Change in Percent Time spent in Moderate to Vigorous Physical Activity (MVPA)
Time Frame: Change from baseline in MVPA at 6 months
|
Waist-worn accelerometer
|
Change from baseline in MVPA at 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Chantelle N Hart, PhD, Temple University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2018
Primary Completion (Actual)
January 31, 2023
Study Completion (Actual)
September 30, 2023
Study Registration Dates
First Submitted
March 31, 2017
First Submitted That Met QC Criteria
June 12, 2017
First Posted (Actual)
June 14, 2017
Study Record Updates
Last Update Posted (Actual)
January 5, 2024
Last Update Submitted That Met QC Criteria
January 3, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01HL092910 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Optimize Sleep (OS)
-
The Miriam HospitalTemple UniversityCompletedObesity | SleepUnited States
-
Northwestern UniversityRecruitingPregnancy RelatedUnited States
-
French Defence Health ServiceCompleted
-
University of MinnesotaRecruitingDeep Brain Stimulation | Refractory EpilepsyUnited States
-
University College, LondonMedical Research Council; Moorfields Eye Hospital NHS Foundation TrustRecruiting
-
Vedic Lifesciences Pvt. Ltd.Completed
-
University of Texas at AustinNational Institute of Nursing Research (NINR); Fordham UniversityCompleted
-
Ivory Graft Ltd.Active, not recruitingAlveolar Bone Grafting | Deficiency of Alveolar Ridge (Disorder) | Mandibular Prosthesis UserIsrael
-
Zagazig UniversityNot yet recruitingCervical IO Plasty in Management of Placenta Previa
-
University of NebraskaPhilips Medical SystemsTerminatedDiffuse and Focal Abnormalities of the Liver and PancreasUnited States